Cover Image

How to treat hypertension in Venlafaxine-medicated patients: pharmacokinetic considerations in prescribing Amlodipine and Ramipril

Background - Amlodipine (AMLO) and ramipril (RAMI) belong to the most prescribed drugs in patients with hypertension, a condition also encountered in depression. Venlafaxine may worsen hypertension because of noradrenergic properties. Although of special clinical relevance, data on pharmacokinetic i...

Full description

Saved in:
Bibliographic Details
Main Authors: Augustin, Marc (Author) , Schoretsanitēs, Geōrgios (Author) , Gründer, Gerhard (Author) , Haen, Ekkehard (Author) , Paulzen, Michael (Author)
Format: Article (Journal)
Language:English
Published: June 27, 2018
In: Journal of clinical psychopharmacology
Year: 2018, Volume: 38, Issue: 5, Pages: 498-501
ISSN:1533-712X
DOI:10.1097/JCP.0000000000000929
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1097/JCP.0000000000000929
Verlag, lizenzpflichtig, Volltext: https://journals.lww.com/psychopharmacology/Fulltext/2018/10000/How_to_Treat_Hypertension_in_Venlafaxine_Medicated.15.aspx
Get full text
Author Notes:Marc Augustin, MD, Georgios Schoretsanitis, MD, Gerhard Gründer, MD, Ekkehard Haen, MD and Michael Paulzen, MD

MARC

LEADER 00000caa a2200000 c 4500
001 170053002X
003 DE-627
005 20240406193212.0
007 cr uuu---uuuuu
008 200612s2018 xx |||||o 00| ||eng c
024 7 |a 10.1097/JCP.0000000000000929  |2 doi 
035 |a (DE-627)170053002X 
035 |a (DE-599)KXP170053002X 
035 |a (OCoLC)1341339576 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Augustin, Marc  |d 1986-  |e VerfasserIn  |0 (DE-588)1070021202  |0 (DE-627)823190668  |0 (DE-576)429700636  |4 aut 
245 1 0 |a How to treat hypertension in Venlafaxine-medicated patients  |b pharmacokinetic considerations in prescribing Amlodipine and Ramipril  |c Marc Augustin, MD, Georgios Schoretsanitis, MD, Gerhard Gründer, MD, Ekkehard Haen, MD and Michael Paulzen, MD 
264 1 |c June 27, 2018 
300 |a 4 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 12.06.2020 
520 |a Background - Amlodipine (AMLO) and ramipril (RAMI) belong to the most prescribed drugs in patients with hypertension, a condition also encountered in depression. Venlafaxine may worsen hypertension because of noradrenergic properties. Although of special clinical relevance, data on pharmacokinetic interactions between AMLO, RAMI, and venlafaxine (VEN) are lacking. - Methods - Two TDM databases consisting of plasma concentrations of VEN and its active metabolite O-desmethylvenlafaxine (ODVEN) were analyzed. We considered a group of patients comedicated with AMLO, VAMLO (n = 22); a group comedicated with RAMI, VRAMI (n = 20); and a 4:1 control group age matched to the VAMLO group receiving VEN without confounding medications, V0 (n = 88). Plasma concentrations of VEN, ODVEN, and active moiety, AM (VEN + ODVEN); metabolic ratio (ODVEN/VEN); and dose-adjusted plasma concentrations (C/D) were compared using nonparametric tests. - Results - Groups did not differ in daily VEN dose, age, or sex. The metabolic ratio (ODVEN/VEN) was lower in the AMLO group (P = 0.029), whereas the RAMI group showed lower values for ODVEN (P = 0.029). All other parameters showed no significant differences. - Conclusions - Significantly lower values for the metabolic ratio in the AMLO group are unlikely to be explained by cytochrome P450 (CYP) 3A4 and weak CYP2D6 inhibition by AMLO. Other factors such as differences in CYP2D6 polymorphisms and metabolizer status may better explain the findings. Ramipril showed modest effects with changes in ODVEN concentrations that did not remain significant after dose-adjusted comparisons. 
700 1 |a Schoretsanitēs, Geōrgios  |d 1953-  |e VerfasserIn  |0 (DE-588)1169687679  |0 (DE-627)1035290197  |0 (DE-576)512198446  |4 aut 
700 1 |a Gründer, Gerhard  |e VerfasserIn  |0 (DE-588)1078251037  |0 (DE-627)838195350  |0 (DE-576)449927644  |4 aut 
700 1 |a Haen, Ekkehard  |e VerfasserIn  |0 (DE-588)1154391795  |0 (DE-627)1015677347  |0 (DE-576)500705852  |4 aut 
700 1 |a Paulzen, Michael  |d 1974-  |e VerfasserIn  |0 (DE-588)124425755  |0 (DE-627)36333856X  |0 (DE-576)294165983  |4 aut 
773 0 8 |i Enthalten in  |t Journal of clinical psychopharmacology  |d Hagerstown, Md. : Lippincott Williams & Wilkins, 1981  |g 38(2018), 5, Seite 498-501  |h Online-Ressource  |w (DE-627)33428998X  |w (DE-600)2057059-4  |w (DE-576)098000314  |x 1533-712X  |7 nnas  |a How to treat hypertension in Venlafaxine-medicated patients pharmacokinetic considerations in prescribing Amlodipine and Ramipril 
773 1 8 |g volume:38  |g year:2018  |g number:5  |g pages:498-501  |g extent:4  |a How to treat hypertension in Venlafaxine-medicated patients pharmacokinetic considerations in prescribing Amlodipine and Ramipril 
856 4 0 |u https://doi.org/10.1097/JCP.0000000000000929  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://journals.lww.com/psychopharmacology/Fulltext/2018/10000/How_to_Treat_Hypertension_in_Venlafaxine_Medicated.15.aspx  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20200612 
993 |a Article 
994 |a 2018 
998 |g 1078251037  |a Gründer, Gerhard  |m 1078251037:Gründer, Gerhard  |d 60000  |e 60000PG1078251037  |k 0/60000/  |p 3 
999 |a KXP-PPN170053002X  |e 3686699281 
BIB |a Y 
SER |a journal 
JSO |a {"recId":"170053002X","origin":[{"dateIssuedDisp":"June 27, 2018","dateIssuedKey":"2018"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"id":{"eki":["170053002X"],"doi":["10.1097/JCP.0000000000000929"]},"physDesc":[{"extent":"4 S."}],"relHost":[{"title":[{"title":"Journal of clinical psychopharmacology","title_sort":"Journal of clinical psychopharmacology"}],"language":["eng"],"part":{"year":"2018","text":"38(2018), 5, Seite 498-501","volume":"38","issue":"5","extent":"4","pages":"498-501"},"pubHistory":["1.1981 -"],"type":{"bibl":"periodical","media":"Online-Ressource"},"origin":[{"dateIssuedDisp":"1981-","publisher":"Lippincott Williams & Wilkins ; Ovid","dateIssuedKey":"1981","publisherPlace":"Hagerstown, Md. ; [Erscheinungsort nicht ermittelbar]"}],"recId":"33428998X","physDesc":[{"extent":"Online-Ressource"}],"id":{"issn":["1533-712X"],"zdb":["2057059-4"],"eki":["33428998X"]},"disp":"How to treat hypertension in Venlafaxine-medicated patients pharmacokinetic considerations in prescribing Amlodipine and RamiprilJournal of clinical psychopharmacology","note":["Gesehen am 21.06.2019"]}],"note":["Gesehen am 12.06.2020"],"name":{"displayForm":["Marc Augustin, MD, Georgios Schoretsanitis, MD, Gerhard Gründer, MD, Ekkehard Haen, MD and Michael Paulzen, MD"]},"person":[{"role":"aut","given":"Marc","display":"Augustin, Marc","family":"Augustin"},{"role":"aut","given":"Geōrgios","display":"Schoretsanitēs, Geōrgios","family":"Schoretsanitēs"},{"family":"Gründer","display":"Gründer, Gerhard","given":"Gerhard","role":"aut"},{"display":"Haen, Ekkehard","given":"Ekkehard","role":"aut","family":"Haen"},{"display":"Paulzen, Michael","role":"aut","given":"Michael","family":"Paulzen"}],"title":[{"subtitle":"pharmacokinetic considerations in prescribing Amlodipine and Ramipril","title":"How to treat hypertension in Venlafaxine-medicated patients","title_sort":"How to treat hypertension in Venlafaxine-medicated patients"}],"language":["eng"]} 
SRT |a AUGUSTINMAHOWTOTREAT2720 

Similar Items